Business UpdateJul 27, 2026, 08:27 AM
SciSparc to Target Agentic AI Market; Forms Advisory Board
AI Summary
SciSparc Ltd. announced a strategic decision by its board of directors to target the agentic artificial intelligence (AI) market. As part of this initiative, the company plans to establish a Scientific Advisory Board dedicated to AI and cybersecurity. SciSparc is actively evaluating opportunities and engaging in discussions with several companies in the agentic AI field, while maintaining its existing focus on cannabinoid pharmaceutical developments through its subsidiary NeuroThera.
Key Highlights
- SciSparc's board decided to target the agentic artificial intelligence (AI) market.
- Company will establish a Scientific Advisory Board focused on AI and cybersecurity.
- SciSparc is evaluating opportunities and in discussions with AI companies.
- Company's existing focus is on cannabinoid pharmaceuticals via NeuroThera.
- Drug programs include SCI-110 for Tourette's, Alzheimer's, and SCI-210 for Autism.
- NeuroThera also controls a subsidiary selling hemp seed oil products on Amazon.
Price Impact
More from SPRC